International Clinical Trial: Evaluation of the Safety and Efficacy of Nalbuphine for Early Analgesia in Severe Acute Pancreatitis: A Multicenter Randomized Controlled Trial

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132759) titled 'Evaluation of the Safety and Efficacy of Nalbuphine for Early Analgesia in Severe Acute Pancreatitis: A Multicenter Randomized Controlled Trial' on Sept. 18.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Affiliated Hospital of Anhui Medical University

Condition: Severe Acute Pancreatitis (SAP)

Intervention: Experimental group:Patients in the study group receive nalbuphine for analgesia. A loading dose of 0.1 mg/kg is administered via intravenous pump over 10-15 minutes, followed by a continuous maintenance infusion at 2.4-7.24 mg/h. Analgesic effect is assessed every ...